Akebia Therapeutics, Inc.
AKBA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001517022
No open-market purchases or sales by Akebia Therapeutics, Inc. insiders were filed in the last 90 days; 170 institutions reported holding it in 13F filings for Q2 2026, worth $123.2M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Akebia Therapeutics, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 121
- +9 vs. Q3 2024
- Shares held
- 67.8M
- +8.47M (+14.3%) vs. Q3 2024
- Total value
- $128.9M
- +$50.5M (+64.5%) vs. Q3 2024
- New holders
- 24
- 47 more added
- Sold out
- 15
- 19 more reduced
2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AKBA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 170 | $123.2M |
| Q1 2026 | 171 | $141.4M |
| Q4 2025 | 166 | $190.4M |
| Q3 2025 | 177 | $337.7M |
| Q2 2025 | 158 | $394.1M |
| Q1 2025 | 143 | $182.7M |
| Q4 2024 | 121 | $128.9M |
| Q3 2024 | 114 | $78.4M |
| Q2 2024 | 103 | $57.4M |
| Q1 2024 | 114 | $104.3M |
| Q4 2023 | 87 | $72.7M |
| Q3 2023 | 76 | $58.0M |
| Q2 2023 | 79 | $46.0M |
| Q1 2023 | 65 | $29.1M |
| Q4 2022 | 75 | $30.2M |
| Q3 2022 | 90 | $16.5M |
| Q2 2022 | 97 | $20.2M |
| Q1 2022 | 124 | $58.3M |
| Q4 2021 | 133 | $218.7M |
| Q3 2021 | 127 | $283.7M |
| Q2 2021 | 139 | $402.4M |
| Q1 2021 | 145 | $340.3M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Akebia Therapeutics, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 456,294 | $867.0K | 0.00% | +357,748+363.0% | Added |
| Bank of New York Mellon Corp | 497,547 | $945.3K | 0.00% | +27,839+5.9% | Added |
| Wellington Management Group LLP | 502,127 | $954.0K | 0.00% | +97,409+24.1% | Added |
| Bank of America Corp | 543,916 | $1.03M | 0.00% | +294,343+117.9% | Added |
| Susquehanna International Group, LLP | 586,097 | $1.11M | 0.00% | +421,527+256.1% | Added |
| Charles Schwab Investment Management Inc | 586,710 | $1.11M | 0.00% | +18,043+3.2% | Added |
| FMR LLC | 747,006 | $1.42M | 0.00% | +64,968+9.5% | Added |
| Federated Hermes, Inc. | 914,003 | $1.74M | 0.00% | +45,982+5.3% | Added |
| Goldman Sachs Group Inc | 1,002,194 | $1.90M | 0.00% | +516,925+106.5% | Added |
| Connor, Clark & Lunn Investment Management Ltd. | 1,026,896 | $1.95M | 0.01% | −19,795−1.9% | Reduced |
| Qube Research & Technologies Ltd | 1,191,359 | $2.26M | 0.00% | −132,370−10.0% | Reduced |
| Jacobs Levy Equity Management, Inc | 1,228,710 | $2.33M | 0.01% | −805,459−39.6% | Reduced |
| Citadel Advisors LLC | 1,382,146 | $2.63M | 0.00% | +1,382,146 | New |
| Northern Trust Corp | 1,685,641 | $3.20M | 0.00% | +50,542+3.1% | Added |
| Morgan Stanley | 1,790,051 | $3.40M | 0.00% | +701,159+64.4% | Added |
| Renaissance Technologies LLC | 3,823,527 | $7.26M | 0.01% | +105,727+2.8% | Added |
| Geode Capital Management, LLC | 4,795,095 | $9.11M | 0.00% | +40,631+0.9% | Added |
| Satter Management Co., L.P. | 5,747,906 | $10.9M | 19.23% | 00.0% | Unchanged |
| State Street Corp | 6,304,698 | $12.0M | 0.00% | +2,874,171+83.8% | Added |
| Vanguard Group Inc | 10,884,200 | $20.7M | 0.00% | +813,902+8.1% | Added |
| BlackRock, Inc. | 15,097,625 | $28.7M | 0.00% | −99,582−0.7% | Reduced |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −142,274−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −140,167−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −133,934−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −55,746−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −48,016−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −44,267−100.0% | Sold out |
| Mercer Global Advisors Inc | 0 | $0 | 0.00% | −38,721−100.0% | Sold out |
| GTS Securities LLC | 0 | $0 | 0.00% | −34,389−100.0% | Sold out |
| Compass Ion Advisors, LLC | 0 | $0 | 0.00% | −25,095−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −24,848−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −12,306−100.0% | Sold out |
| CIBC Private Wealth Group, LLC | 0 | $0 | 0.00% | −2,825−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −2,116−100.0% | Sold out |
| Baldwin Brothers Inc | 0 | $0 | 0.00% | −561−100.0% | Sold out |
| Capital Performance Advisors LLP | 0 | $0 | 0.00% | −68−100.0% | Sold out |
| Raymond James & Associates | – | – | – | – | Not filed |
| Cedrus LLC | – | – | – | – | Not filed |